TriSalus Life Sciences, Inc. (TLSIW) › Shareholders' EquityTriSalus Life Sciences, Inc. (TLSIW) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2020: -$21.48M2021: -$129.60M2022: -$177.13M2023: -$27.07M2024: -$25.89M2025: -$33.86M-$33.86M2020Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$33.86M-30.8%2024-$25.89M+4.3%2023-$27.07M+84.7%2022-$177.13M-36.7%2021-$129.60M-503.3%2020-$21.48M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share